Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT03123458
PHASE1

Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders

Sponsor: Shenzhen Geno-Immune Medical Institute

View on ClinicalTrials.gov

Summary

The primary objectives are to evaluate the safety and efficacy of infusion of the third party fully-characterized clonally derived fetal MSCs (cfMSCs) for the control of severe symptoms associated with acute and chronic immune-related disorders and tissue damage.

Key Details

Gender

All

Age Range

1 Year - 80 Years

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2025-01-01

Completion Date

2029-12-31

Last Updated

2025-09-08

Healthy Volunteers

No

Interventions

BIOLOGICAL

clonal fetal MSCs

clonal fetal MSCs

Locations (3)

Capital Institute of Pediatrics affiliated Children's hospital

Beijing, Beijing Municipality, China

Shenzhen Geno-immune Medical Institute

Shenzhen, Guangdong, China

Aerospace Center Hospital

Beijing, China